BIIB vs ECL · P/E 21, rev $9.89B vs P/E 35, rev $4.01B
Biogen Inc (BIIB) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BIIB and ECL stock pages for the full models.
Not investment advice.